ATE38675T1 - Phosphatesterderivate und ihre verwendung als anti-krebsmittel. - Google Patents

Phosphatesterderivate und ihre verwendung als anti-krebsmittel.

Info

Publication number
ATE38675T1
ATE38675T1 AT86300278T AT86300278T ATE38675T1 AT E38675 T1 ATE38675 T1 AT E38675T1 AT 86300278 T AT86300278 T AT 86300278T AT 86300278 T AT86300278 T AT 86300278T AT E38675 T1 ATE38675 T1 AT E38675T1
Authority
AT
Austria
Prior art keywords
sup
phosphate ester
cancer agent
ester derivatives
sub
Prior art date
Application number
AT86300278T
Other languages
English (en)
Inventor
Norio Sankyo Chemical Nakamura
Hiromachi
Hideki Sankyo Chemica Miyazaki
Fusaaki Sankyo Chemica Shimizu
Kazuhiko Sankyo Chemi Sasagawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE38675T1 publication Critical patent/ATE38675T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65525Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
AT86300278T 1985-01-16 1986-01-16 Phosphatesterderivate und ihre verwendung als anti-krebsmittel. ATE38675T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP405485 1985-01-16
EP86300278A EP0188384B1 (de) 1985-01-16 1986-01-16 Phosphatesterderivate und ihre Verwendung als Anti-Krebsmittel

Publications (1)

Publication Number Publication Date
ATE38675T1 true ATE38675T1 (de) 1988-12-15

Family

ID=11574166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86300278T ATE38675T1 (de) 1985-01-16 1986-01-16 Phosphatesterderivate und ihre verwendung als anti-krebsmittel.

Country Status (8)

Country Link
US (1) US4794183A (de)
EP (1) EP0188384B1 (de)
JP (1) JPS61267592A (de)
AT (1) ATE38675T1 (de)
CA (1) CA1299575C (de)
DE (1) DE3661198D1 (de)
ES (1) ES8704918A1 (de)
IE (1) IE860134L (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891363A (en) * 1985-07-26 1990-01-02 Sankyo Company Limited Cyclic ether derivatives and their use
DE3666435D1 (en) * 1985-08-30 1989-11-23 Sandoz Ag Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体
KR950002551B1 (en) * 1986-07-04 1995-03-21 Sankyo Co Cyclic ether derivatives, their preparation and use
US5192766A (en) * 1989-04-28 1993-03-09 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists
US5369106A (en) * 1989-04-28 1994-11-29 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists
US5248790A (en) * 1992-06-30 1993-09-28 E. R. Squibb & Sons, Inc. Aminoalkylphosphonic acid esters of natural 4-methoxy-5-methyl-pyran-3-ol and derivatives thereof
US10913767B2 (en) * 2010-04-22 2021-02-09 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising acyclic and abasic nucleosides and analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
ZA866591B (en) * 1985-08-30 1988-04-27 Sandoz Ltd Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides,processes for their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
IE860134L (en) 1986-07-16
US4794183A (en) 1988-12-27
JPS61267592A (ja) 1986-11-27
EP0188384A1 (de) 1986-07-23
CA1299575C (en) 1992-04-28
ES550971A0 (es) 1987-04-16
DE3661198D1 (en) 1988-12-22
ES8704918A1 (es) 1987-04-16
EP0188384B1 (de) 1988-11-17

Similar Documents

Publication Publication Date Title
NZ216363A (en) Quinazoline derivatives and pharmaceutical compositions
NO901392L (no) Immunomodulerende azaspiraner.
ES2035261T3 (es) Composiciones de crudos de petroleo y fueloleos.
NO173867C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
DE68910441D1 (de) Spiro-Verbindungen.
ATE117681T1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
DE3778508D1 (de) Substituierte triazinderivate.
ES2163617T3 (es) Derivados antiinflamatorios de acido benzoico.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE69050T1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
DE69415314D1 (de) Neue bisoxadiazolidinderivate
SE8303913L (sv) Heterocykliska foreningar
DE69017794D1 (de) Aminoketonderivate und ihre Verwendung.
DE3783821D1 (de) Tetracyclische indolderivate.
ATE65986T1 (de) Propanolabkoemmlinge.
ES2055094T3 (es) Utilizacion de poliaminas oxidadas, en particular nn'-bis-(3-propionaldehido)-1-4-diaminobutano (dialdehido espermina) como agentes inmunosupresores.
IT1201444B (it) Fosfonopiridine a loro 1,4-diidroderivati